Assessment of three fasting plasma glucose targets for insulin glargine-based therapy in people with type 2 diabetes mellitus in China: study protocol for a randomized controlled trial
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s13063-016-1588-6
Published Online: 2016-09-26
Published Print: 2016-12
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Yang, Wenying
Yang, Zhaojun
Zhao, Jing
Lu, Hai
Luo, Tianhong
Funding for this research was provided by:
Sanofi China Investment Co.
License valid from 2016-09-26